The complainant has requested information about adverse reactions to approved COVID-19 vaccines. The Medicines and Healthcare Products Regulatory Agency (MHRA) is withholding the information under section 22(1) of the FOIA as it intends to publish it at some future date. The Commissioner’s decision is as follows: MHRA is entitled to withhold the requested information under section 22(1) of the FOIA and the public interest favours maintaining the exemption. MHRA’s refusal notice was inadequate and did not meet the requirements of section 17(3) of the FOIA. The Commissioner does not require MHRA to take any remedial steps.
FOI 17: Complaint upheld FOI 22: Complaint not upheld
Citations:
[2022] UKICO ic-107706
Links:
Jurisdiction:
England and Wales
Information
Updated: 10 November 2022; Ref: scu.674797